Schizoaffective Disorders Terminated Phase 4 Trials for Amantadine (DB00915)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Terminated4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00975611Study of Amantadine for Risperidone Consta or Paliperidone Treated Patients to Decrease Prolactin ElevationTreatment